van der Graaf F, Rietveld A, Keus F J, Bouma B N
Biochemistry. 1984 Apr 10;23(8):1760-6. doi: 10.1021/bi00303a027.
Human plasma kallikrein participates in the contact activation system of plasma. The light chain of kallikrein contains the enzymatic active site; the heavy chain is required for binding to high molecular weight kininogen and for surface-dependent activation of coagulation. This study has examined the functional contributions of the heavy chain of kallikrein and of high molecular weight kininogen in the inactivation of kallikrein and of its isolated light chain by alpha 2-macroglobulin (alpha 2M). Irreversible inhibition was observed for both kallikrein and its light chain, with the initial formation of a reversible enzyme-inhibitor complex. The second-order rate constants for these reactions were 3.5 X 10(5) and 4.8 X 10(5) M-1 min-1 for kallikrein and its light chain, respectively. When present in excess, high molecular weight kininogen decreased the rate of kallikrein inactivation by alpha 2M, whereas the rate of inactivation of the light chain was unaffected by high molecular weight kininogen. Although at a drastically reduced rate, high molecular weight kininogen was cleaved by alpha 2M-bound kallikrein. Sodium dodecyl sulfate gradient polyacrylamide gel electrophoresis was used to study complex formation between alpha 2M and kallikrein or its light chain. Under reducing conditions, four kallikrein-alpha 2M complexes were observed. Three of these complexes consisted of alpha 2M and the light chain of kallikrein (Mr 123 000, 235 000, and 330 000). Two alpha 2M-kallikrein light chain complexes incorporated [3H]diisopropyl fluorophosphate ( [3H]DFP) whereas the Mr 330 000 complex did not react with [3H]DFP.(ABSTRACT TRUNCATED AT 250 WORDS)
人血浆激肽释放酶参与血浆接触激活系统。激肽释放酶的轻链含有酶活性位点;重链对于与高分子量激肽原结合以及表面依赖性凝血激活是必需的。本研究检测了激肽释放酶重链和高分子量激肽原在α2 -巨球蛋白(α2M)使激肽释放酶及其分离的轻链失活过程中的功能作用。观察到激肽释放酶及其轻链均发生不可逆抑制,最初形成可逆的酶 - 抑制剂复合物。这些反应的二级速率常数对于激肽释放酶及其轻链分别为3.5×10⁵和4.8×10⁵ M⁻¹ min⁻¹。当高分子量激肽原过量存在时,它降低了α2M使激肽释放酶失活的速率,而轻链的失活速率不受高分子量激肽原影响。尽管速率大幅降低,但高分子量激肽原被α2M结合的激肽释放酶裂解。使用十二烷基硫酸钠梯度聚丙烯酰胺凝胶电泳研究α2M与激肽释放酶或其轻链之间的复合物形成。在还原条件下,观察到四种激肽释放酶 - α2M复合物。其中三种复合物由α2M和激肽释放酶轻链组成(分子量分别为123000、235000和330000)。两种α2M - 激肽释放酶轻链复合物结合了[³H]二异丙基氟磷酸酯([³H]DFP),而分子量为330000的复合物不与[³H]DFP反应。(摘要截短至250字)